Copper Complexes as Anticancer Agents Targeting Topoisomerases I and II
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Copper Complexes as Anticancer Agents Targeting Topoisomerases I and II
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 10, Pages 2863
Publisher
MDPI AG
Online
2020-10-05
DOI
10.3390/cancers12102863
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first‐line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group
- (2020) Lorenzo D’Ambrosio et al. CANCER
- Current Biomedical Use of Copper Chelation Therapy
- (2020) Silvia Baldari et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Role of VEGFs/VEGFR-1 Signaling and Its Inhibition in Modulating Tumor Invasion: Experimental Evidence in Different Metastatic Cancer Models
- (2020) Claudia Ceci et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Topoisomerase 1 cleavage complex enables pattern recognition and inflammation during senescence
- (2020) Bo Zhao et al. Nature Communications
- Targeting the RNA Polymerase I Transcription for Cancer Therapy Comes of Age
- (2020) Rita Ferreira et al. Cells
- Hypoxia imaging and theranostic potential of [64Cu][Cu(ATSM)] and ionic Cu(II) salts: a review of current evidence and discussion of the retention mechanisms
- (2020) Tengzhi Liu et al. EJNMMI Research
- Copper Coordination Compounds as Biologically Active Agents
- (2020) Olga Krasnovskaya et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Enhancing anti-tumor response by combining immune checkpoint inhibitors with chemotherapy in solid tumors
- (2019) K M Heinhuis et al. ANNALS OF ONCOLOGY
- Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins
- (2019) Rumani Singh et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The mitochondrial type IB topoisomerase drives mitochondrial translation and carcinogenesis
- (2019) S. A. Baechler et al. Nature Communications
- Cisplatin-Membrane Interactions and Their Influence on Platinum Complexes Activity and Toxicity
- (2019) Nuno Martinho et al. Frontiers in Physiology
- Spotlight on liposomal irinotecan for metastatic pancreatic cancer: patient selection and perspectives
- (2019) Wonhee Woo et al. OncoTargets and Therapy
- The Specific Inhibition of SOD1 Selectively Promotes Apoptosis of Cancer Cells via Regulation of the ROS Signaling Network
- (2019) Xiang Li et al. Oxidative Medicine and Cellular Longevity
- Current pharmacotherapy for testicular germ cell cancer
- (2019) Winfried Alsdorf et al. EXPERT OPINION ON PHARMACOTHERAPY
- Tetrazolo[1,5-a]pyrimidine-based metal(II) complexes as therapeutic agents: DNA interaction, targeting topoisomerase I and cyclin-dependent kinase studies
- (2019) Azees Khan Haleel et al. Inorganic and Nano-Metal Chemistry
- Twist and Turn—Topoisomerase Functions in Mitochondrial DNA Maintenance
- (2019) Steffi Goffart et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Activating cGAS-STING pathway for the optimal effect of cancer immunotherapy
- (2019) Anping Li et al. Journal of Hematology & Oncology
- Dual DNA topoisomerase 1 and tyrosyl‐DNA phosphodiesterase 1 inhibition for improved anticancer activity
- (2019) Alexandra Zakharenko et al. MEDICINAL RESEARCH REVIEWS
- Schlafen 11 (SLFN11), a restriction factor for replicative stress induced by DNA-targeting anti-cancer therapies
- (2019) Junko Murai et al. PHARMACOLOGY & THERAPEUTICS
- Pixantrone beyond monotherapy: a review
- (2019) Cristina Barrenetxea Lekue et al. ANNALS OF HEMATOLOGY
- Targeting Topoisomerase I in the Era of Precision Medicine
- (2019) Anish Thomas et al. CLINICAL CANCER RESEARCH
- A comprehensive review of topoisomerase inhibitors as anticancer agents in the past decade
- (2019) Xiaoxia Liang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- CDC25B and CDC25C overexpression in nonmelanoma skin cancer suppresses cell death
- (2019) Jenan Al-Matouq et al. MOLECULAR CARCINOGENESIS
- Clarifying the Mechanism of Copper(II) α-(N)-Heterocyclic Thiosemicarbazone Complexes on DNA Topoisomerase IIα and IIβ
- (2019) J. Myles Keck et al. CHEMICAL RESEARCH IN TOXICOLOGY
- New Insights into Mechanisms of Cisplatin Resistance: From Tumor Cell to Microenvironment
- (2019) Shang-Hung Chen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Idarubicin, cytarabine, and nivolumab in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a single-arm, phase 2 study
- (2019) Farhad Ravandi et al. Lancet Haematology
- cGAS/STING axis mediates a topoisomerase II inhibitor–induced tumor immunogenicity
- (2019) Zining Wang et al. JOURNAL OF CLINICAL INVESTIGATION
- Dual Inhibitors of Human DNA Topoisomerase II and Other Cancer-Related Targets
- (2019) Žiga Skok et al. JOURNAL OF MEDICINAL CHEMISTRY
- Identifying new topoisomerase II poison scaffolds by combining publicly available toxicity data and 2D/3D-based virtual screening
- (2019) Anna Lovrics et al. Journal of Cheminformatics
- Cell Cycle-Dependent Control and Roles of DNA Topoisomerase II
- (2019) Joyce H. Lee et al. Genes
- From coins to cancer therapy: Gold, silver and copper complexes targeting human topoisomerases
- (2019) Jessica Ceramella et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Treatment of recurrent epithelial ovarian cancer
- (2019) Sandro Pignata et al. CANCER
- Topoisomerase inhibitors: Pharmacology and emerging nanoscale delivery systems
- (2019) Ali Dehshahri et al. PHARMACOLOGICAL RESEARCH
- Properties of FDA-approved small molecule protein kinase inhibitors: A 2020 update
- (2019) Robert Roskoski PHARMACOLOGICAL RESEARCH
- Mechanisms and clinical course of cardiovascular toxicity of cancer treatment I. Oncology
- (2019) Edward T.H. Yeh et al. SEMINARS IN ONCOLOGY
- Autophagy and doxorubicin resistance in cancer
- (2018) Chao Chen et al. ANTI-CANCER DRUGS
- Topoisomerases as anticancer targets
- (2018) Justine L. Delgado et al. BIOCHEMICAL JOURNAL
- Copper complex derived from S-benzyldithiocarbazate and 3-acetylcoumarin induced apoptosis in breast cancer cell
- (2018) Jhi Biau Foo et al. BIOMETALS
- The mechanism of tumour cell death by metal-based anticancer drugs is not only a matter of DNA interactions
- (2018) Alberta Bergamo et al. COORDINATION CHEMISTRY REVIEWS
- Metabolic vulnerability of cisplatin‐resistant cancers
- (2018) Florine Obrist et al. EMBO JOURNAL
- Long-term effect of epirubicin on incidence of heart failure in women with breast cancer: insight from a randomized clinical trial
- (2018) Ann Banke et al. EUROPEAN JOURNAL OF HEART FAILURE
- Suppressing autophagy enhances disulfiram/copper-induced apoptosis in non-small cell lung cancer
- (2018) Xi Wu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Apoptosis: A Target for Anticancer Therapy
- (2018) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Roles of DNA Topoisomerase IIβ in Transcription
- (2018) Ram Madabhushi INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Effect of TDP2 on the Level of TOP2-DNA Complexes and SUMOylated TOP2-DNA Complexes
- (2018) Ka Lee et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Carbohydrate-based heteronuclear complexes as topoisomerase Iα inhibitor: approach toward anticancer chemotherapeutics
- (2018) Mohd. Afzal et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Comparative studies of oxindolimine-metal complexes as inhibitors of human DNA topoisomerase IB
- (2018) Silvia Castelli et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Discovery of Novel Topoisomerase II Inhibitors by Medicinal Chemistry Approaches
- (2018) Wei Hu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Coupling the core of the anticancer drug etoposide to an oligonucleotide induces topoisomerase II-mediated cleavage at specific DNA sequences
- (2018) Lorena Infante Lara et al. NUCLEIC ACIDS RESEARCH
- A Phase II Study of Irinotecan for Patients with Previously Treated Small-Cell Lung Cancer
- (2018) Rie Kondo et al. ONCOLOGY
- Regulation of Tumor Progression by Programmed Necrosis
- (2018) Su Yeon Lee et al. Oxidative Medicine and Cellular Longevity
- Pixantrone: novel mode of action and clinical readouts
- (2018) Giorgio Minotti et al. Expert Review of Hematology
- The effects of mutational processes and selection on driver mutations across cancer types
- (2018) Daniel Temko et al. Nature Communications
- Update on the Treatment of Anaplastic Large Cell Lymphoma
- (2018) Khoan Vu et al. Current Hematologic Malignancy Reports
- Treatment Options for Relapsed Small-Cell Lung Cancer: What Progress Have We Made?
- (2018) Angel Qin et al. Journal of Oncology Practice
- Irinotecan-platinum combination therapy for previously untreated extensive-stage small cell lung cancer patients: a meta-analysis
- (2018) Fei Xu et al. BMC CANCER
- Recent Advances in Copper Intercalators as Anticancer Agents
- (2018) C. Shobha Devi et al. JOURNAL OF FLUORESCENCE
- Recent developments in topoisomerase targeted cancer chemotherapy
- (2018) KirkE. Hevener et al. Acta Pharmaceutica Sinica B
- Targeting Cyclin-Dependent Kinases for Treatment of Gynecologic Cancers
- (2018) Z. Ping Lin et al. Frontiers in Oncology
- Mutant p53 as a guardian of the cancer cell
- (2018) Fiamma Mantovani et al. CELL DEATH AND DIFFERENTIATION
- Structural and Metal Ion Effects on Human Topoisomerase IIα Inhibition by α-(N)-Heterocyclic Thiosemicarbazones
- (2018) William H. Morris et al. CHEMICAL RESEARCH IN TOXICOLOGY
- What is the potential of p53 isoforms as a predictive biomarker in the treatment of cancer?
- (2018) Liam Hayman et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Anthracyclines as Topoisomerase II Poisons: From Early Studies to New Perspectives
- (2018) Jessica Marinello et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- State-of-the-art strategies for targeting the DNA damage response in cancer
- (2018) Patrick G. Pilié et al. Nature Reviews Clinical Oncology
- A genome-wide RNAi screen identifies the SMC5/6 complex as a non-redundant regulator of a Topo2a-dependent G2 arrest
- (2018) Katharina Deiss et al. NUCLEIC ACIDS RESEARCH
- Cyclin-dependent protein serine/threonine kinase inhibitors as anticancer drugs
- (2018) Robert Roskoski PHARMACOLOGICAL RESEARCH
- The chromatin accessibility landscape of primary human cancers
- (2018) M. Ryan Corces et al. SCIENCE
- Emerging therapies in the management of high-risk non-muscle invasive bladder cancer (HRNMIBC)
- (2018) Ryan P. Werntz et al. WORLD JOURNAL OF UROLOGY
- Novel clinical indenoisoquinoline topoisomerase I inhibitors: a twist around the camptothecins
- (2018) Yves Pommier et al. Oncotarget
- ROS and the DNA damage response in cancer
- (2018) Upadhyayula Sai Srinivas et al. Redox Biology
- ATR inhibition disrupts rewired homologous recombination and fork protection pathways in PARP inhibitor-resistant BRCA-deficient cancer cells
- (2017) Stephanie A. Yazinski et al. GENES & DEVELOPMENT
- Systematic Review and Network Meta-Analysis of Bevacizumab Plus First-Line Topotecan-Paclitaxel or Cisplatin-Paclitaxel Versus Non–Bevacizumab-Containing Therapies in Persistent, Recurrent, or Metastatic Cervical Cancer
- (2017) Virginia M. Rosen et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Autophagy Roles in the Modulation of DNA Repair Pathways
- (2017) Luciana Gomes et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A nanoliposome-based photoactivable drug delivery system for enhanced cancer therapy and overcoming treatment resistance
- (2017) Jinjin Shi et al. International Journal of Nanomedicine
- Pharmacophore Hybridization To Discover Novel Topoisomerase II Poisons with Promising Antiproliferative Activity
- (2017) Jose Antonio Ortega et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cisplatin nephrotoxicity: a review of the literature
- (2017) Sandhya Manohar et al. JOURNAL OF NEPHROLOGY
- Advances in the design of organometallic anticancer complexes
- (2017) Pingyu Zhang et al. JOURNAL OF ORGANOMETALLIC CHEMISTRY
- Molecular trail for the anticancer behavior of a novel copper carbohydrazone complex in BRCA1 mutated breast cancer
- (2017) Rakesh Sathish Nair et al. MOLECULAR CARCINOGENESIS
- gamma-H2AX: Can it be established as a classical cancer prognostic factor?
- (2017) Viktoria-Varvara Palla et al. TUMOR BIOLOGY
- Characterization of Cardiovascular Alterations Induced by Different Chronic Cisplatin Treatments
- (2017) Esperanza Herradón et al. Frontiers in Pharmacology
- Heteroleptic Copper(I) Complexes of “Scorpionate” Bis-pyrazolyl Carboxylate Ligand with Auxiliary Phosphine as Potential Anticancer Agents: An Insight into Cytotoxic Mode
- (2017) Rais Ahmad Khan et al. Scientific Reports
- Human topoisomerase IB is a target of a thiosemicarbazone copper(II) complex
- (2016) Venn Vutey et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Synthesis and biological activity of ferrocenyl indeno[1,2-c]isoquinolines as topoisomerase II inhibitors
- (2016) Nathalie Wambang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Platinum-based drugs: past, present and future
- (2016) Shahana Dilruba et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Examination of the Impact of Copper(II) α-(N)-Heterocyclic Thiosemicarbazone Complexes on DNA Topoisomerase IIα
- (2016) James T. Wilson et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Cancer chemoresistance; biochemical and molecular aspects: a brief overview
- (2016) Saeed Kachalaki et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- A novel copper(II) complex identified as a potent drug against colorectal and breast cancer cells and as a poison inhibitor for human topoisomerase IIα
- (2016) Shayna Sandhaus et al. INORGANIC CHEMISTRY COMMUNICATIONS
- Cell cycle checkpoint in cancer: a therapeutically targetable double-edged sword
- (2016) Roberta Visconti et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Topoisomerase I inhibition and DNA cleavage by zinc, copper, and nickel derivatives of 2-[2-bromoethyliminomethyl]-4-[ethoxymethyl]phenol complexes exhibiting anti-proliferation and anti-metastasis activity
- (2016) Sze Koon Lee et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Antioxidant, DNA interaction, VEGFR2 kinase, topoisomerase I and in vitro cytotoxic activities of heteroleptic copper(II) complexes of tetrazolo[1,5- a ]pyrimidines and diimines
- (2016) A. Haleel et al. Materials Science & Engineering C-Materials for Biological Applications
- Novel copper complexes as potential proteasome inhibitors for cancer treatment
- (2016) Zhen Zhang et al. Molecular Medicine Reports
- Roles of eukaryotic topoisomerases in transcription, replication and genomic stability
- (2016) Yves Pommier et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Synthesis, Structure, and Antiproliferative Activity of Ruthenium(II) Arene Complexes of Indenoisoquinoline Derivatives
- (2016) Nathalie Wambang et al. ORGANOMETALLICS
- Systematic Investigation of Expression of G2/M Transition Genes Reveals CDC25 Alteration in Nonfunctioning Pituitary Adenomas
- (2016) Henriett Butz et al. PATHOLOGY & ONCOLOGY RESEARCH
- Cisplatin resistance and opportunities for precision medicine
- (2016) Lauren Amable PHARMACOLOGICAL RESEARCH
- Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer
- (2016) Kyle C. Strickland et al. Oncotarget
- Topoisomerase I in Human Disease Pathogenesis and Treatments
- (2016) Min Li et al. GENOMICS PROTEOMICS & BIOINFORMATICS
- Acute myeloid leukemia-Major progress over four decades and glimpses into the future
- (2015) Hagop Kantarjian AMERICAN JOURNAL OF HEMATOLOGY
- Cellular mechanisms of the cytotoxicity of the anticancer drug elesclomol and its complex with Cu(II)
- (2015) Brian B. Hasinoff et al. BIOCHEMICAL PHARMACOLOGY
- Redox signalling to nuclear regulatory proteins by reactive oxygen species contributes to oestrogen-induced growth of breast cancer cells
- (2015) V O Okoh et al. BRITISH JOURNAL OF CANCER
- Ferrocifen type anti cancer drugs
- (2015) Gérard Jaouen et al. CHEMICAL SOCIETY REVIEWS
- Possible DNA-Interacting Pathways for Metal-Based Compounds Exemplified with Copper Coordination Compounds
- (2015) Rosa F. Brissos et al. EUROPEAN JOURNAL OF INORGANIC CHEMISTRY
- The distinctive cellular responses to DNA strand breaks caused by a DNA topoisomerase I poison in conjunction with DNA replication and RNA transcription
- (2015) Ryo Sakasai et al. GENES & GENETIC SYSTEMS
- Disulfiram/copper-disulfiram Damages Multiple Protein Degradation and Turnover Pathways and Cytotoxicity is Enhanced by Metformin in Oesophageal Squamous Cell Carcinoma Cell Lines
- (2015) Rupal Jivan et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Quinoline-2-carboxaldehyde thiosemicarbazones and their Cu(II) and Ni(II) complexes as topoisomerase IIa inhibitors
- (2015) Franco Bisceglie et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Discovery of Potent Indenoisoquinoline Topoisomerase I Poisons Lacking the 3-Nitro Toxicophore
- (2015) Daniel E. Beck et al. JOURNAL OF MEDICINAL CHEMISTRY
- Behind the Link between Copper and Angiogenesis: Established Mechanisms and an Overview on the Role of Vascular Copper Transport Systems
- (2015) Emanuela Urso et al. JOURNAL OF VASCULAR RESEARCH
- Vosaroxin in acute myeloid leukaemia
- (2015) Martin Bornhäuser LANCET ONCOLOGY
- Mitoxantrone, More than Just Another Topoisomerase II Poison
- (2015) Benny J. Evison et al. MEDICINAL RESEARCH REVIEWS
- Targeting copper in cancer therapy: ‘Copper That Cancer’
- (2015) Delphine Denoyer et al. Metallomics
- Apoptosis, autophagy, necroptosis, and cancer metastasis
- (2015) Zhenyi Su et al. Molecular Cancer
- Redox cycling of a copper complex with benzaldehyde nitrogen mustard-2-pyridine carboxylic acid hydrazone contributes to its enhanced antitumor activity, but no change in the mechanism of action occurs after chelation
- (2015) YINLI YANG et al. ONCOLOGY REPORTS
- Irinotecan, a key chemotherapeutic drug for metastatic colorectal cancer
- (2015) Ken-ichi Fujita WORLD JOURNAL OF GASTROENTEROLOGY
- Dual targeting of microtubule and topoisomerase II by α-carboline derivative YCH337 for tumor proliferation and growth inhibition
- (2015) Jun-Mei Yi et al. Oncotarget
- Topoisomerase II and leukemia
- (2014) MaryJean Pendleton et al. Annals of the New York Academy of Sciences
- Inhibitory effect of Disulfiram/copper complex on non-small cell lung cancer cells
- (2014) Lincan Duan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The many “faces” of copper in medicine and treatment
- (2014) Anna Hordyjewska et al. BIOMETALS
- Copper Signaling Axis as a Target for Prostate Cancer Therapeutics
- (2014) R. Safi et al. CANCER RESEARCH
- Copper complexes with phosphonium containing hydrazone ligand: Topoisomerase inhibition and cytotoxicity study
- (2014) Shin Thung Chew et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- HMGB1 in health and disease
- (2014) Rui Kang et al. MOLECULAR ASPECTS OF MEDICINE
- Disulfiram Suppresses Growth of the Malignant Pleural Mesothelioma Cells in Part by Inducing Apoptosis
- (2014) Vino T. Cheriyan et al. PLoS One
- Zinc, copper and nickel derivatives of 2-[2-bromoethyliminomethyl]phenol as topoisomerase inhibitors exhibiting anti-proliferative and anti-metastatic properties
- (2014) Sze Koon Lee et al. RSC Advances
- Drug Resistance in Cancer: An Overview
- (2014) Genevieve Housman et al. Cancers
- Increasing Intracellular Bioavailable Copper Selectively Targets Prostate Cancer Cells
- (2013) Michael A. Cater et al. ACS Chemical Biology
- The ubiquitin proteasome system — Implications for cell cycle control and the targeted treatment of cancer
- (2013) Florian Bassermann et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Advances in Copper Complexes as Anticancer Agents
- (2013) Carlo Santini et al. CHEMICAL REVIEWS
- Chiral heterobimetallic complexes targeting human DNA-topoisomerase Iα
- (2013) Sartaj Tabassum et al. DALTON TRANSACTIONS
- Copper(II) Complexes with Highly Water-Soluble l- and d-Proline–Thiosemicarbazone Conjugates as Potential Inhibitors of Topoisomerase IIα
- (2013) Felix Bacher et al. INORGANIC CHEMISTRY
- In Vitro and in Vivo Anticancer Activity of Copper Bis(thiosemicarbazone) Complexes
- (2013) Duraippandi Palanimuthu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Effect of oxindolimine copper(ii) and zinc(ii) complexes on human topoisomerase I activity
- (2013) Prafulla Katkar et al. Metallomics
- Signatures of mutational processes in human cancer
- (2013) Ludmil B. Alexandrov et al. NATURE
- BAF complexes facilitate decatenation of DNA by topoisomerase IIα
- (2013) Emily C. Dykhuizen et al. NATURE
- STK295900, a Dual Inhibitor of Topoisomerase 1 and 2, Induces G2 Arrest in the Absence of DNA Damage
- (2013) Sun-Ok Kim et al. PLoS One
- Drugging Topoisomerases: Lessons and Challenges
- (2012) Yves Pommier ACS Chemical Biology
- Copper Complexes as Anticancer Agents
- (2012) Cristina Marzano et al. Anti-Cancer Agents in Medicinal Chemistry
- Biological and cytoselective anticancer properties of copper(II)-polypyridyl complexes modulated by auxiliary methylated glycine ligand
- (2012) Hoi-Ling Seng et al. BIOMETALS
- Contemporary Challenges in the Design of Topoisomerase II Inhibitors for Cancer Chemotherapy
- (2012) Christian Bailly CHEMICAL REVIEWS
- Enantiomeric Specificity of Biologically Significant Cu(II) and Zn(II) Chromone Complexes Towards DNA
- (2012) Farukh Arjmand et al. CHIRALITY
- Next-Generation Anticancer Metallodrugs
- (2012) Seiji Komeda et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Molecular drug design, synthesis and structure elucidation of a new specific target peptide based metallo drug for cancer chemotherapy as topoisomerase I inhibitor
- (2012) Sartaj Tabassum et al. DALTON TRANSACTIONS
- Copper levels in patients with hematological malignancies
- (2012) Georgia D. Kaiafa et al. European Journal of Internal Medicine
- Anti-cancer activity and mutagenic potential of novel copper(II) quinolinone Schiff base complexes in hepatocarcinoma cells
- (2012) Brian Duff et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Chemotherapy for Initial Induction Failures in Childhood Acute Lymphoblastic Leukemia
- (2012) Michael J. Joyce et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Synthesis of heterobimetallic complexes: In vitro DNA binding, cleavage and antimicrobial studies
- (2012) Sartaj Tabassum et al. JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY
- Anticancer Activity of Metal Complexes: Involvement of Redox Processes
- (2011) Ute Jungwirth et al. ANTIOXIDANTS & REDOX SIGNALING
- Asperlin induces G2/M arrest through ROS generation and ATM pathway in human cervical carcinoma cells
- (2011) Long He et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Clioquinol induces cytoplasmic clearance of the X-linked inhibitor of apoptosis protein (XIAP): therapeutic indication for prostate cancer
- (2011) Michael A. Cater et al. BIOCHEMICAL JOURNAL
- Revised genetic requirements for the decatenation G2 checkpoint: The role of ATM
- (2011) Jacquelyn J. Bower et al. CELL CYCLE
- Role of Metalation in the Topoisomerase IIα Inhibition and Antiproliferation Activity of a Series of α-Heterocyclic-N4-Substituted Thiosemicarbazones and Their Cu(II) Complexes
- (2011) Brian M. Zeglis et al. JOURNAL OF MEDICINAL CHEMISTRY
- New Topoisomerase I mutations are associated with resistance to camptothecin
- (2011) Céline Gongora et al. Molecular Cancer
- Mitotic catastrophe: a mechanism for avoiding genomic instability
- (2011) Ilio Vitale et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Homologous recombination in cancer development, treatment and development of drug resistance
- (2010) T. Helleday CARCINOGENESIS
- DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs
- (2010) Yves Pommier et al. CHEMISTRY & BIOLOGY
- Turning Tumor-Promoting Copper into an Anti-Cancer Weapon via High-Throughput Chemistry
- (2010) F. Wang et al. CURRENT MEDICINAL CHEMISTRY
- A Series of α-Heterocyclic Carboxaldehyde Thiosemicarbazones Inhibit Topoisomerase IIα Catalytic Activity
- (2010) He Huang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Topoisomerase IIα maintains genomic stability through decatenation G2 checkpoint signaling
- (2010) J J Bower et al. ONCOGENE
- Analysis of inhibition of topoisomerase IIα and cancer cell proliferation by ingenolEZ
- (2009) Chisato Yoshida et al. CANCER SCIENCE
- Copper Compounds in Anticancer Strategies
- (2009) Saverio Tardito et al. CURRENT MEDICINAL CHEMISTRY
- Doxorubicin: The Good, the Bad and the Ugly Effect
- (2009) Cristina Carvalho et al. CURRENT MEDICINAL CHEMISTRY
- A categorization of metal anticancer compounds based on their mode of action
- (2009) Teresa Gianferrara et al. DALTON TRANSACTIONS
- Cytotoxicity of the traditional chinese medicine (TCM) plumbagin in its copper chemistry
- (2009) Zhen-Feng Chen et al. DALTON TRANSACTIONS
- Ataxia telangiectasia mutated activation by transcription- and topoisomerase I-induced DNA double-strand breaks
- (2009) Olivier Sordet et al. EMBO REPORTS
- Pyrophosphate-bridged complexes with picomolar toxicity
- (2009) Oluwatayo F. Ikotun et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- A human 5′-tyrosyl DNA phosphodiesterase that repairs topoisomerase-mediated DNA damage
- (2009) Felipe Cortes Ledesma et al. NATURE
- Bioorganometallic chemistry—from teaching paradigms to medicinal applications
- (2008) Christian G. Hartinger et al. CHEMICAL SOCIETY REVIEWS
- DNA-damage repair; the good, the bad, and the ugly
- (2008) Razqallah Hakem EMBO JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search